Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease pandemic
Eur J Cancer
.
2020 Jun:132:8-10.
doi: 10.1016/j.ejca.2020.03.023.
Epub 2020 Apr 6.
Authors
Paolo Tarantino
1
,
Dario Trapani
2
,
Giuseppe Curigliano
3
Affiliations
1
European Institute of Oncology, IRCCS, Milan, Italy; University of Milan, Milan, Italy.
2
European Institute of Oncology, IRCCS, Milan, Italy.
3
European Institute of Oncology, IRCCS, Milan, Italy; University of Milan, Milan, Italy. Electronic address: Giuseppe.curigliano@ieo.it.
PMID:
32305011
PMCID:
PMC7136890
DOI:
10.1016/j.ejca.2020.03.023
No abstract available
Publication types
Letter
MeSH terms
Betacoronavirus*
COVID-19
Clinical Protocols
Clinical Trials, Phase I as Topic*
Coronavirus Infections*
Humans
Neoplasms / drug therapy*
Pandemics*
Pneumonia, Viral*
SARS-CoV-2